M
Mastologia
1 PDF(s) · 56 diretriz(es)
Documentos para Download:
- PDF Brca1 e brca2 em câncer de mama
- DIR Abemaciclibe — Câncer de mama precoce, receptor hormonal positivo, receptor do fator de crescimento epidérmico humano 2 (HER2) negativo, linfonodo positivo e com alto risco de recorrência
- DIR Advanced breast cancer: diagnosis and treatment
- DIR Advanced breast cancer: diagnosis and treatment (CG81)
- DIR Breast cancer
- DIR Breast cancer in women: diagnosis, treatment and follow-up
- DIR Breast cancer nutrition
- DIR Breast Cancer Reconstruction Surgery (Immediate and Delayed) Across Ontario: Patient Indications and Appropriate Surgical Options 17-10v2
- DIR Breastfeeding - Promoting and Supporting the Initiation, Exclusivity, and Continuation of Breastfeeding in Newborns, Infants and Young Children, Third Edition
- DIR Breastfeeding programs in acute and primary healthcare settings (Best Practice 15(3))
- DIR Câncer de Mama
- DIR Clinical Practice Guideline on Breastfeeding
- DIR Clinical Utility of Multigene Profiling Assays in Invasive Early-Stage Breast Cancer 4v3
- DIR COST EVALUATION OF THE EARLy BREAST CANCER DETECTION PROGRAMME OF THE AUTONOMOUS COMMUNITy OF THE BASqUE COUNTRY
- DIR Criteria for appropriate use of FDG-PET in breast cancer
- DIR Digital mammograms in breast cancer screening. Assessment of their efficiency and inclusion in the Early Breast Cancer Detection Programme of the Basque Country
- DIR Diretrizes Diagnósticas e Terapêuticas — Carcinoma de Mama
- DIR Diretrizes Diagnósticas e Terapêuticas — Carcinoma de Mama
- DIR Diretrizes Diagnósticas e Terapêuticas — Carcinoma de Mama
- DIR Diretrizes Diagnósticas e Terapêuticas — Carcinoma de Mama
- DIR Diretrizes Nacionais — Detecção Precoce do Câncer de Mama
- DIR Early and locally advanced breast cancer: diagnosis and management
- DIR Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
- DIR EVALUATION OF CARE TIMES FOR THE MAIN CANCER SITES: COLON/RECTUM, LUNG, BREAST AND PROSTATE
- DIR Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer
- DIR Hormonioterapia prévia — Câncer de mama
- DIR Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
- DIR Improving outcomes in breast cancer (CSG1)
- DIR INFORMATION REQUIRED FOR ANALYSING THE IMPACT OF THE EARLY BREAST CANCER DETECTION PROGRAMME
- DIR Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline
- DIR Locoregional Therapy of Locally Advanced Breast Cancer 1-19
- DIR Mamografia — Rastreamento do câncer de mama em mulheres assintomáticas com risco habitual fora da faixa etária atualmente recomendada (50 a 69 anos)
- DIR Management of Breast Cancer (Third Edition)
- DIR Management of ductal carcinoma in situ of the breast
- DIR Management of Male Breast Cancer: ASCO Guideline
- DIR Management of the Axilla in Early-Stage Breast Cancer
- DIR New imaging techniques in the diagnosis of breast cancer: digital mammography and electrical impedance and conductivity
- DIR New percutaneous techniques of histological diagnosis of non palpable lesions suspected of breast cancer
- DIR Optimal Systemic Therapy for Early Female Breast Cancer 1-21
- DIR Pertuzumabe e trastuzumabe em combinação — Combinação de dose fixa subcutânea no tratamento neoadjuvante de pacientes com câncer de mama HER2-positivo
- DIR Protocolo Clínico e Diretrizes Terapêuticas — Câncer de Mama
- DIR Quantitative Image Analysis of HER2 Immunohistochemistry for Breast Cancer
- DIR Radioterapia Intraoperatória — Tumores de Mama
- DIR Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians
- DIR Study on the extension of the age of the target population screening program for breast cancer in the Basque Country
- DIR Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Clinical Practice Guideline Update
- DIR The Management of Nipple Pain and/or Trauma Associated with Breastfeeding (Best practice 7(3))
- DIR The management of nipple pain and/or trauma associated with breastfeeding (Best Practice 13(4))
- DIR The Utility of PET/CT in Breast Cancer (Stages II-IV): An Evidence Summary 14
- DIR Trastuzumabe — Câncer de mama avançado
- DIR Trastuzumabe — Câncer de mama HER2-positivometastático em primeira linhade tratamento
- DIR Trastuzumabe — Câncer de mama inicial
- DIR Trastuzumabe entansina — Tratamento adjuvante do câncer de mama HER2-positivo operado em estádio III com doença residual na peça cirúrgica após tratamento neoadjuvante
- DIR Treatment of primary breast cancer (SIGN CPG 134)
- DIR Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer 1-22-Av2
- DIR Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update
- DIR Women’s perceptions and experiences of breastfeeding support (Best Practice 14(7))
